Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 362

1.

Expression of Concern: Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes (doi:10.1242/jcs.02784).

Guerriero R, Parolini I, Testa U, Samoggia P, Petrucci E, Sargiacomo M, Chelucci C, Gabbianelli M, Peschle C.

J Cell Sci. 2019 Aug 15;132(16). pii: jcs237495. doi: 10.1242/jcs.237495. No abstract available.

PMID:
31416852
2.

Expression of Concern: Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes (doi:10.1242/jcs.02784).

Guerriero R, Parolini I, Testa U, Samoggia P, Petrucci E, Sargiacomo M, Chelucci C, Gabbianelli M, Peschle C.

J Cell Sci. 2019 May 31;132(11). pii: jcs233684. doi: 10.1242/jcs.233684. No abstract available.

PMID:
31152055
3.

Correction: Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes (doi:10.1242/jcs.02784).

Guerriero R, Parolini I, Testa U, Samoggia P, Petrucci E, Sargiacomo M, Chelucci C, Gabbianelli M, Peschle C.

J Cell Sci. 2019 May 31;132(11). pii: jcs233676. doi: 10.1242/jcs.233676. No abstract available.

PMID:
31152054
4.

Regulation of monocytopoiesis by microRNAs.

Fontana L, Sorrentino A, Peschle C.

Methods Mol Biol. 2010;667:165-76. doi: 10.1007/978-1-60761-811-9_11.

PMID:
20827533
5.

Hematopoietic differentiation: a coordinated dynamical process towards attractor stable states.

Felli N, Cianetti L, Pelosi E, Carè A, Liu CG, Calin GA, Rossi S, Peschle C, Marziali G, Giuliani A.

BMC Syst Biol. 2010 Jun 16;4:85. doi: 10.1186/1752-0509-4-85.

6.

A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells.

Starnes LM, Sorrentino A, Ferracin M, Negrini M, Pelosi E, Nervi C, Peschle C.

Leukemia. 2010 Jun;24(6):1220-3. doi: 10.1038/leu.2010.78. Epub 2010 Apr 29. No abstract available.

PMID:
20428206
7.

Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex.

Gabbianelli M, Testa U, Morsilli O, Pelosi E, Saulle E, Petrucci E, Castelli G, Giovinazzi S, Mariani G, Fiori ME, Bonanno G, Massa A, Croce CM, Fontana L, Peschle C.

Haematologica. 2010 Aug;95(8):1253-60. doi: 10.3324/haematol.2009.018259. Epub 2010 Mar 19.

8.

Correlations between progression of coronary artery disease and circulating endothelial progenitor cells.

Briguori C, Testa U, Riccioni R, Colombo A, Petrucci E, Condorelli G, Mariani G, D'Andrea D, De Micco F, Rivera NV, Puca AA, Peschle C, Condorelli G.

FASEB J. 2010 Jun;24(6):1981-8. doi: 10.1096/fj.09-138198. Epub 2010 Jan 7.

PMID:
20056714
9.

NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls beta-globin and G-CSF receptor expression.

Starnes LM, Sorrentino A, Pelosi E, Ballarino M, Morsilli O, Biffoni M, Santoro S, Felli N, Castelli G, De Marchis ML, Mastroberardino G, Gabbianelli M, Fatica A, Bozzoni I, Nervi C, Peschle C.

Blood. 2009 Aug 27;114(9):1753-63. doi: 10.1182/blood-2008-12-196196. Epub 2009 Jun 19.

10.

MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis.

Felli N, Pedini F, Romania P, Biffoni M, Morsilli O, Castelli G, Santoro S, Chicarella S, Sorrentino A, Peschle C, Marziali G.

Haematologica. 2009 Apr;94(4):479-86. doi: 10.3324/haematol.2008.002345. Epub 2009 Mar 10.

11.

Role of microRNAs in haemopoiesis, heart hypertrophy and cancer.

Fontana L, Sorrentino A, Condorelli G, Peschle C.

Biochem Soc Trans. 2008 Dec;36(Pt 6):1206-10. doi: 10.1042/BST0361206. Review.

PMID:
19021526
12.

MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors.

Romania P, Lulli V, Pelosi E, Biffoni M, Peschle C, Marziali G.

Br J Haematol. 2008 Nov;143(4):570-80. doi: 10.1111/j.1365-2141.2008.07382.x.

PMID:
18950466
13.

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.

Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De Maria R.

Nat Med. 2008 Nov;14(11):1271-7. doi: 10.1038/nm.1880. Epub 2008 Oct 19.

PMID:
18931683
14.

Role of microRNAs in drug-resistant ovarian cancer cells.

Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C.

Gynecol Oncol. 2008 Dec;111(3):478-86. doi: 10.1016/j.ygyno.2008.08.017. Epub 2008 Sep 26.

PMID:
18823650
15.

A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis.

Labbaye C, Spinello I, Quaranta MT, Pelosi E, Pasquini L, Petrucci E, Biffoni M, Nuzzolo ER, Billi M, Foà R, Brunetti E, Grignani F, Testa U, Peschle C.

Nat Cell Biol. 2008 Jul;10(7):788-801. doi: 10.1038/ncb1741. Epub 2008 Jun 22.

PMID:
18568019
16.

Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.

Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, Peschle C, Valtieri M.

Exp Hematol. 2008 Aug;36(8):1035-46. doi: 10.1016/j.exphem.2008.03.004. Epub 2008 May 27.

PMID:
18504067
17.

Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM.

Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M, Boldrini R, Donfrancesco A, Federici V, Giacomini P, Peschle C, Fruci D.

PLoS One. 2008 May 21;3(5):e2236. doi: 10.1371/journal.pone.0002236.

18.

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.

Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Carè A.

Cancer Res. 2008 Apr 15;68(8):2745-54. doi: 10.1158/0008-5472.CAN-07-2538.

19.

Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels.

Riccioni R, Senese M, Diverio D, Riti V, Mariani G, Boe A, LoCoco F, Foà R, Peschle C, Sporn M, Testa U.

Leuk Res. 2008 Aug;32(8):1244-58. doi: 10.1016/j.leukres.2007.12.008. Epub 2008 Mar 4.

PMID:
18304628
20.

The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation.

Rosa A, Ballarino M, Sorrentino A, Sthandier O, De Angelis FG, Marchioni M, Masella B, Guarini A, Fatica A, Peschle C, Bozzoni I.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19849-54. Epub 2007 Dec 3.

21.

Identification and expansion of the tumorigenic lung cancer stem cell population.

Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R.

Cell Death Differ. 2008 Mar;15(3):504-14. Epub 2007 Nov 30.

22.

A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells.

Gallo P, Grimaldi S, Latronico MV, Bonci D, Pagliuca A, Gallo P, Ausoni S, Peschle C, Condorelli G.

Gene Ther. 2008 Feb;15(3):161-70. Epub 2007 Nov 22.

PMID:
18033312
23.

Effective erythropoiesis and HbF reactivation induced by kit ligand in beta-thalassemia.

Gabbianelli M, Morsilli O, Massa A, Pasquini L, Cianciulli P, Testa U, Peschle C.

Blood. 2008 Jan 1;111(1):421-9. Epub 2007 Oct 19.

24.

M4 and M5 acute myeloid leukaemias display a high sensitivity to Bortezomib-mediated apoptosis.

Riccioni R, Senese M, Diverio D, Riti V, Buffolino S, Mariani G, Boe A, Cedrone M, Lo-Coco F, Foà R, Peschle C, Testa U.

Br J Haematol. 2007 Oct;139(2):194-205.

PMID:
17897295
25.

MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation.

Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F, Croce CM, Brunetti E, Grignani F, Peschle C.

Nat Cell Biol. 2007 Jul;9(7):775-87. Epub 2007 Jun 24.

PMID:
17589498
26.

Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia.

Invernici G, Emanueli C, Madeddu P, Cristini S, Gadau S, Benetti A, Ciusani E, Stassi G, Siragusa M, Nicosia R, Peschle C, Fascio U, Colombo A, Rizzuti T, Parati E, Alessandri G.

Am J Pathol. 2007 Jun;170(6):1879-92.

27.

Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor.

Zeuner A, Signore M, Martinetti D, Bartucci M, Peschle C, De Maria R.

Cancer Res. 2007 May 15;67(10):4767-73.

28.

Methylation damage response in hematopoietic progenitor cells.

Casorelli I, Pelosi E, Biffoni M, Cerio AM, Peschle C, Testa U, Bignami M.

DNA Repair (Amst). 2007 Aug 1;6(8):1170-8. Epub 2007 May 15.

PMID:
17507295
29.

MicroRNA-133 controls cardiac hypertrophy.

Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G.

Nat Med. 2007 May;13(5):613-8. Epub 2007 Apr 29.

PMID:
17468766
30.

Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.

Riccioni R, Diverio D, Mariani G, Buffolino S, Riti V, Saulle E, Petrucci E, Cedrone M, Lo-Coco F, Foà R, Peschle C, Testa U.

Stem Cells. 2007 Aug;25(8):1862-71. Epub 2007 Apr 19.

31.

Transferrin receptor 2 is frequently expressed in human cancer cell lines.

Calzolari A, Oliviero I, Deaglio S, Mariani G, Biffoni M, Sposi NM, Malavasi F, Peschle C, Testa U.

Blood Cells Mol Dis. 2007 Jul-Aug;39(1):82-91. Epub 2007 Apr 10.

PMID:
17428703
32.

A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.

Petrucci E, Pasquini L, Petronelli A, Saulle E, Mariani G, Riccioni R, Biffoni M, Ferretti G, Benedetti-Panici P, Cognetti F, Scambia G, Humphreys R, Peschle C, Testa U.

Gynecol Oncol. 2007 May;105(2):481-92. Epub 2007 Feb 9.

PMID:
17292950
33.

Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis.

Saulle E, Petronelli A, Pasquini L, Petrucci E, Mariani G, Biffoni M, Ferretti G, Scambia G, Benedetti-Panici P, Cognetti F, Humphreys R, Peschle C, Testa U.

Apoptosis. 2007 Apr;12(4):635-55.

PMID:
17252198
34.

Human neural progenitor cells display limited cytotoxicity and increased oligodendrogenesis during inflammation.

Ricci-Vitiani L, Lombardi DG, Signore M, Biffoni M, Pallini R, Parati E, Peschle C, De Maria R.

Cell Death Differ. 2007 Apr;14(4):876-8. Epub 2006 Dec 22. No abstract available.

35.

Identification and expansion of human colon-cancer-initiating cells.

Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R.

Nature. 2007 Jan 4;445(7123):111-5. Epub 2006 Nov 19.

PMID:
17122771
36.

Podocalyxin is expressed in normal and leukemic monocytes.

Riccioni R, Calzolari A, Biffoni M, Senese M, Riti V, Petrucci E, Pasquini L, Cedrone M, Lo-Coco F, Diverio D, Foà R, Peschle C, Testa U.

Blood Cells Mol Dis. 2006 Nov-Dec;37(3):218-25. Epub 2006 Oct 23.

PMID:
17059890
37.

TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway.

Calzolari A, Raggi C, Deaglio S, Sposi NM, Stafsnes M, Fecchi K, Parolini I, Malavasi F, Peschle C, Sargiacomo M, Testa U.

J Cell Sci. 2006 Nov 1;119(Pt 21):4486-98. Epub 2006 Oct 17.

38.

Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: Focus on DNA repair genes.

Casorelli I, Tenedini E, Tagliafico E, Blasi MF, Giuliani A, Crescenzi M, Pelosi E, Testa U, Peschle C, Mele L, Diverio D, Breccia M, Lo-Coco F, Ferrari S, Bignami M.

Leukemia. 2006 Nov;20(11):1978-88. Epub 2006 Sep 21.

PMID:
16990782
39.

Glycated fibroblast growth factor-2 is quickly produced in vitro upon low-millimolar glucose treatment and detected in vivo in diabetic mice.

Facchiano F, D'Arcangelo D, Russo K, Fogliano V, Mennella C, Ragone R, Zambruno G, Carbone V, Ribatti D, Peschle C, Capogrossi MC, Facchiano A.

Mol Endocrinol. 2006 Nov;20(11):2806-18. Epub 2006 Jul 13.

PMID:
16840537
40.

Lentiviral transduction of human postnatal skeletal (stromal, mesenchymal) stem cells: in vivo transplantation and gene silencing.

Piersanti S, Sacchetti B, Funari A, Di Cesare S, Bonci D, Cherubini G, Peschle C, Riminucci M, Bianco P, Saggio I.

Calcif Tissue Int. 2006 Jun;78(6):372-84. Epub 2006 Jun 21.

PMID:
16830199
41.

Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord.

Ricci-Vitiani L, Casalbore P, Petrucci G, Lauretti L, Montano N, Larocca LM, Falchetti ML, Lombardi DG, Gerevini VD, Cenciarelli C, D'Alessandris QG, Fernandez E, De Maria R, Maira G, Peschle C, Parati E, Pallini R.

Neurol Res. 2006 Jul;28(5):488-92.

PMID:
16808877
42.

Sources of cardiomyocytes for stem cell therapy: an update.

Gallo P, Peschle C, Condorelli G.

Pediatr Res. 2006 Apr;59(4 Pt 2):79R-83R. Review.

PMID:
16549553
43.

Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina.

Briguori C, Reimers B, Sarais C, Napodano M, Pascotto P, Azzarello G, Bregni M, Porcellini A, Vinante O, Zanco P, Peschle C, Condorelli G, Colombo A.

Am Heart J. 2006 Mar;151(3):674-80.

PMID:
16504630
44.

Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals.

Briguori C, Testa U, Colombo A, Petrucci E, Condorelli G, Airoldi F, Peschle C, Condorelli G.

Am J Cardiol. 2006 Feb 15;97(4):472-6. Epub 2005 Dec 20.

PMID:
16461039
45.

Chemotherapy resistance of glioblastoma stem cells.

Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, De Maria R.

Cell Death Differ. 2006 Jul;13(7):1238-41. Epub 2006 Feb 3. No abstract available.

46.

Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes.

Guerriero R, Parolini I, Testa U, Samoggia P, Petrucci E, Sargiacomo M, Chelucci C, Gabbianelli M, Peschle C.

J Cell Sci. 2006 Feb 15;119(Pt 4):744-52. Epub 2006 Jan 31. Erratum in: J Cell Sci. 2019 May 31;132(11):. Erratum in: J Cell Sci. 2019 Aug 15;132(16):.

47.

Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells.

Zeuner A, Pedini F, Signore M, Ruscio G, Messina C, Tafuri A, Girelli G, Peschle C, De Maria R.

Blood. 2006 May 1;107(9):3495-502. Epub 2005 Dec 29.

48.

In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation.

Saulle E, Riccioni R, Pelosi E, Stafness M, Mariani G, De Tuglie G, Peschle C, Testa U.

Blood Cells Mol Dis. 2006 Jan-Feb;36(1):59-76. Epub 2005 Dec 15.

PMID:
16360329
49.

Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.

Eramo A, Pallini R, Lotti F, Sette G, Patti M, Bartucci M, Ricci-Vitiani L, Signore M, Stassi G, Larocca LM, Crinò L, Peschle C, De Maria R.

Cancer Res. 2005 Dec 15;65(24):11469-77.

50.

MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation.

Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, Valtieri M, Calin GA, Liu CG, Sorrentino A, Croce CM, Peschle C.

Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18081-6. Epub 2005 Dec 5.

Supplemental Content

Loading ...
Support Center